Next Article in Journal
Whole-Exome Sequencing Reveals the Genomic Features of the Micropapillary Component in Ground-Glass Opacities
Next Article in Special Issue
Prediction of Radiotherapy Compliance in Elderly Cancer Patients Using an Internally Validated Decision Tree
Previous Article in Journal
Updated Systematic Review on the Role of Brain Invasion in Intracranial Meningiomas: What, When, Why?
Previous Article in Special Issue
Sequential Hypofractionated versus Concurrent Twice-Daily Radiotherapy for Limited-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis
 
 
Article
Peer-Review Record

As Easy as 1, 2, 3? How to Determine CBCT Frequency in Adjuvant Breast Radiotherapy

Cancers 2022, 14(17), 4164; https://doi.org/10.3390/cancers14174164
by Yannis Junker 1, Mathias Düsberg 1, Rebecca Asadpour 1, Sophie Klusen 1, Stefan Münch 1, Denise Bernhardt 1, Stephanie Elisabeth Combs 1,2,3 and Kai Joachim Borm 1,*
Reviewer 2:
Cancers 2022, 14(17), 4164; https://doi.org/10.3390/cancers14174164
Submission received: 24 July 2022 / Revised: 25 August 2022 / Accepted: 26 August 2022 / Published: 27 August 2022
(This article belongs to the Special Issue Personalized Radiation Therapy for Oncology)

Round 1

Reviewer 1 Report

Interesting paper confirming that accuracy in patient’s positioning is important in adjuvant Breast radiation therapy

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Reviewer 2 Report

Thank you for allowing me to review this article.

The authors report data of interest and importance to radiotherapists. However, I cannot entirely agree with the conclusions/interpretation of the results. I also recommend some further clarifications.

 

Materials and Methods:

I am surprised that the CTV has been expanded by 10mm to the PTV. This, of course, has clear consequences for evaluating the setup errors in terms of "CTV coverage". Why 10mm? Are there any literature references for this? Usually, 5 mm is specified for expansion to compensate for intra- and interfraction positioning errors (see literature: Michalski A et al. Inter- and intra-fraction motion during radiation therapy to the whole breast in supine position: A systematic review. J Med Imag Radiat Oncol 2012;54:499-509).

 

Results, line 137 ff.

What values are given in the brackets? The range (min-max) or the standard deviations? Please define clearly.

 

3.2. Correlation of setup error on days 1-3…

You report a "moderate correlation". What is that, and how is it defined, especially in distinction to "significant correlation"? Please define and specify precisely.

 

4. Discussion

The discussion details that the setup errors during the first 3 fractions do not correlate with the setup errors during the other irradiations. This is, of course, an interesting finding.

However, completely missing from the discussion is that the setup errors were neither correlated with CTV coverage nor OAR exposure. This calls into question the significance of the first finding: -> If the CTV is covered sufficiently anyway and at the same time the OARs are not additionally exposed to radiation (with set up on the first 3 fractions vs. daily CBCT), then – to my mind - it is clinically irrelevant to perform daily CBCT.

In this context, the expansion of the CTV to the PTV must also be discussed, which should not only compensate for the intrafractional motions but also the daily positioning errors. This concept seems to work; as in this study, the positioning errors were not associated with the CTV coverage.

Please discuss these issues in detail.

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Round 2

Reviewer 2 Report

All the comments I have made have been adequately answered by the authors and - where necessary - incorporated into the manuscript. Therefore, I believe the manuscript can be published in the present version.

Back to TopTop